(UroToday.com) At the 2021 Society of Nuclear Medicine & Molecular Imaging (SNMMI) Meeting’s Correlative Cross-Sectional and Molecular Imaging session, Dr. Preeti Sukerkar discussed CT and MRI appearances of benign and malignant lesions in prostate cancer. Dr. Sukerkar notes that there are several important points to consider when assessing bone lesions, including the patient’s age, history, symptoms, and the lesion size, location and number.